Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cyril Pellaton
With
Aktiia SA
Age
21–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult subjects (aged between 21 and 65)
Subjects fluent in written and spoken French
Subjects enrolled in a 12-weeks cardiac rehabilitation program
Subjects agreeing to participate
Subjects that have signed the informed consent form
You may not be if
Subjects with tachycardia (heart rate at rest \> 120bpm)
Subjects with atrial fibrillation
Subjects with severe heart failure (LVEF\<35%)
Subjects with severe renal dysfunctions (eGFR \< 30mL/min/1.73 m2)
Subjects with pheochromocytoma
Subjects with Raynaud's disease
Subjects with trembling and shivering
Subjects with interarm systolic difference \> 15 mmHg
Subjects with interarm diastolic difference \> 10 mmHg
Subjects with arm paralysis
Women in known pregnancy
Subjects with an arteriovenous fistula
Subjects with arm amputations
Subjects with the upper arm circumference \> 64 cm
Subjects with the wrist circumference \> 22 cm
Subjects with the exfoliative skin diseases
Subjects with lymphoedema
Clareo Health | Single-center Prospective Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Ambulatory Blood Pressure Monitoring (ABPM)
